Atlas Trials

Efficacy Study of Nifedipine Controlled-Release Tablets (Xin Ran) to Treat Early Morning Blood Pressure and Central Arterial Pressure

Clinical trial NCT02357615 · UNKNOWN

Trial details

NCT number
NCT02357615
Sponsor
Shanghai Shyndec Pharmaceutical Co., Ltd.
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Essential Hypertension
Start date
2014-12-01
Primary completion
2015-06-01
Enrollment
244

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.